In another study carried out in 2018, Benjamin N. Ostendorf et al. highlighted the aberrant expression of several markers, including ALDH, CLL-1, CD44, and CD47, as specific hematopoietic features in MDS patients with excess blasts. Here, CLEC12A is linked to myelodysplastic syndrome.